Last reviewed · How we verify
Health & Aging Brain Study: Health Disparities TAU Project
trial testing PET scan of the brain with Flortaucipir in Brain Aging in Mexican Americans in 16 participants. Completed in 20 April 2021.
| Lead sponsor | Sid E. O'Bryant |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 16 |
| Start date | 23 September 2019 |
| Primary completion | 17 October 2019 |
| Estimated completion | 20 April 2021 |
| Sites | 1 location across United States |
Sid E. O'Bryant
50 and older, any sex, with Brain Aging in Mexican Americans. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Tau PET scan completed and radiologist reviewed imaging and provided a report on whether or not Tau protein was present in the brain.
| Group | Value | 95% CI |
|---|---|---|
| Tau PET Scan Completed | 12 |
By doing this study we are trying to learn more about brain aging in Mexican Americans. Participants will be asked to complete a screening visit to determine if it is safe to undergo a PET scan. If eligible, participants will undergo a medical procedure that takes a picture of their brain. This procedure is called a PET scan of the brain.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04324541.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing